U.S. flag

An official website of the United States government

NM_000195.5(HPS1):c.972dup (p.Met325fs) AND Hermansky-Pudlak syndrome

Germline classification:
Pathogenic/Likely pathogenic (5 submissions)
Last evaluated:
Dec 14, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000612428.9

Allele description [Variation Report for NM_000195.5(HPS1):c.972dup (p.Met325fs)]

NM_000195.5(HPS1):c.972dup (p.Met325fs)

Genes:
MIR4685:microRNA 4685 [Gene - HGNC]
HPS1:HPS1 biogenesis of lysosomal organelles complex 3 subunit 1 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
10q24.2
Genomic location:
Preferred name:
NM_000195.5(HPS1):c.972dup (p.Met325fs)
Other names:
p.Met325HisfsX128; NM_000195.5(HPS1):c.972dup; p.Met325fs
HGVS:
  • NC_000010.11:g.98427237dup
  • NG_009646.1:g.24718dup
  • NM_000195.5:c.972dupMANE SELECT
  • NM_001311345.2:c.-1dup
  • NM_001322476.2:c.972dup
  • NM_001322477.2:c.972dup
  • NM_001322478.2:c.873dup
  • NM_001322479.2:c.873dup
  • NM_001322480.2:c.711dup
  • NM_001322481.2:c.711dup
  • NM_001322482.2:c.612dup
  • NM_001322483.2:c.603dup
  • NM_001322484.2:c.603dup
  • NM_001322485.2:c.504dup
  • NM_001322487.2:c.-1dup
  • NM_001322489.2:c.-1dup
  • NP_000186.2:p.Met325fs
  • NP_001298274.1:p.Met1fs
  • NP_001309405.1:p.Met325fs
  • NP_001309406.1:p.Met325fs
  • NP_001309407.1:p.Met292fs
  • NP_001309408.1:p.Met292fs
  • NP_001309409.1:p.Met238fs
  • NP_001309410.1:p.Met238fs
  • NP_001309411.1:p.Met205fs
  • NP_001309412.1:p.Met202fs
  • NP_001309413.1:p.Met202fs
  • NP_001309414.1:p.Met169fs
  • NP_001309416.1:p.Met1fs
  • NP_001309418.1:p.Met1fs
  • LRG_562t1:c.972dup
  • LRG_562:g.24718dup
  • LRG_562p1:p.Met325fs
  • NC_000010.10:g.100186986_100186987insG
  • NC_000010.10:g.100186994dup
  • NM_000195.2:c.972dupC
  • NM_000195.3:c.972dup
  • NM_000195.3:c.972dupC
  • NM_000195.4:c.972dup
  • NM_000195.5:c.972dupCMANE SELECT
Protein change:
M169fs
Links:
OMIM: 604982.0002; dbSNP: rs281865082
NCBI 1000 Genomes Browser:
rs281865082
Molecular consequence:
  • NM_000195.5:c.972dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001311345.2:c.-1dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001322476.2:c.972dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001322477.2:c.972dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001322478.2:c.873dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001322479.2:c.873dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001322480.2:c.711dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001322481.2:c.711dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001322482.2:c.612dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001322483.2:c.603dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001322484.2:c.603dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001322485.2:c.504dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001322487.2:c.-1dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001322489.2:c.-1dup - frameshift variant - [Sequence Ontology: SO:0001589]
Functional consequence:
variation affecting RNA [Variation Ontology: 0297]
Observations:
1

Condition(s)

Name:
Hermansky-Pudlak syndrome (HPS)
Synonyms:
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells
Identifiers:
MONDO: MONDO:0019312; MedGen: C0079504; OMIM: PS203300

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000713081Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Pathogenic
(Feb 27, 2017)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

SCV000899377NIHR Bioresource Rare Diseases, University of Cambridge - ThromboGenomics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Feb 1, 2019)
unknownresearch

PubMed (2)
[See all records that cite these PMIDs]

SCV001455566Natera, Inc.
no assertion criteria provided
Pathogenic
(Sep 16, 2020)
germlineclinical testing

SCV002097069Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Nov 29, 2021)
germlinecuration

PubMed (1)
[See all records that cite this PMID]

SCV004241435Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Dec 14, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided11not providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation
Europeanunknownyes4not providednot provided4not providedresearch
South-Asianunknownyes1not providednot provided1not providedresearch

Citations

PubMed

Molecular, ultrastructural and functional characterization of a Spanish family with Hermansky-Pudlak syndrome: role of insC974 in platelet function and clinical relevance.

González-Conejero R, Rivera J, Escolar G, Zuazu-Jausoro I, Vicente V, Corral J.

Br J Haematol. 2003 Oct;123(1):132-8.

PubMed [citation]
PMID:
14510955

High frequency of Hermansky-Pudlak syndrome type 1 (HPS1) among Japanese albinism patients and functional analysis of HPS1 mutant protein.

Ito S, Suzuki T, Inagaki K, Suzuki N, Takamori K, Yamada T, Nakazawa M, Hatano M, Takiwaki H, Kakuta Y, Spritz RA, Tomita Y.

J Invest Dermatol. 2005 Oct;125(4):715-20.

PubMed [citation]
PMID:
16185271
See all PubMed Citations (8)

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000713081.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (5)

Description

The p.Met325fs variant in HPS1 has been reported in 5 Caucasian and 3 Japanese i ndividuals with Hermansky-Pudlak syndrome (Oh 1996, Oh 1998, Gonzalez-Conejero 2 003, Ito 2005). Three individuals were homozygous for this variant and 5 were co mpound heterozygous with a second truncating variant in HPS1. The homozygous all ele also segregated with disease in 5 additional family members in a consanguine ous Swiss family (Oh 1996). This variant has been reported in ClinVar (Variation ID 5278). This variant has been identified in 0.4% (31/8034) of European chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs281865083). This frequency is low enough to be consistent with a recess ive carrier frequency. In vitro functional studies provide some evidence that th e p.Met325fs variant may impact protein function (Gonzalez-Conejero 2003). This variant is predicted to cause a frameshift, which alters the protein?s amino aci d sequence beginning at position 325 and leads to a premature termination codon 128 amino acids downstream. This alteration is then predicted to lead to a trunc ated or absent protein. In summary, this variant meets criteria to be classified as pathogenic for HPS in an autosomal recessive manner based upon prevalence in cases and segregation studies.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided1not provided1not provided

From NIHR Bioresource Rare Diseases, University of Cambridge - ThromboGenomics, SCV000899377.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1European1not providednot providedresearch PubMed (2)
2European1not providednot providedresearch PubMed (2)
3European1not providednot providedresearch PubMed (2)
4European1not providednot providedresearch PubMed (2)
5South-Asian1not providednot providedresearch PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyes1not providednot provided1not providednot providednot provided
2unknownyes1not providednot provided1not providednot providednot provided
3unknownyes1not providednot provided1not providednot providednot provided
4unknownyes1not providednot provided1not providednot providednot provided
5unknownyes1not providednot provided1not providednot providednot provided

From Natera, Inc., SCV001455566.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard, SCV002097069.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (1)

Description

The p.Met325fs (c.972dup) variant in HPS1 has been reported in at least 9 individuals with Hermansky-Pudlak syndrome (PMID: 9497254, 14510955, 16185271, 31141302, 8896559), segregated with disease in 5 affected relatives from 1 family (PMID: 8896559) and has been identified in 0.04% (26/71358) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs281865083). Although this variant has been seen in the general population in a heterozygous state, its frequency is not high enough to rule out a pathogenic role. It is of note that this variant occurs in a homopolymer repeat, which could indicate that it exists as an artifact from sequencing. However, disease-causing variants have been reported in homopolymer regions, so this is not enough to rule out a pathogenic role. This variant has also been reported in ClinVar (Variation ID#: 5278) and has been interpreted as likely pathogenic or pathogenic by NIHR Bioresource Rare Diseases (University of Cambridge), GeneDx, Laboratory for Molecular Medicine (Partners HealthCare Personalized Medicine), Institute of Human Genetics (University of Leipzig Medical Center), Center for Pediatric Genomic Medicine (Children's Mercy Hospital and Clinics), OMIM, Natera, Inc., NIHR Bioresource Rare Diseases (University of Cambridge), Invitae, and GeneReviews. Of the at least 9 affected individuals, 3 of those were homozygotes, which increases the likelihood that the p.Met325fs variant is pathogenic (PMID: 8896559, 9497254). In vitro functional studies provide some evidence that the p.Met325fs variant may slightly impact protein function (PMID: 14510955). However, these types of assays may not accurately represent biological function. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 325 and leads to a premature termination codon 128 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the HPS1 gene is an established disease mechanism in autosomal recessive Hermansky-Pudlak syndrome. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Hermansky-Pudlak syndrome. ACMG/AMP Criteria applied: PM3, PP1_strong, PVS1, PS3_moderate (Richards 2015).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004241435.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant summary: HPS1 c.972dupC (p.Met325HisfsX128) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The frequency data for this variant in gnomAD is considered unreliable, as metrics indicate poor data quality at this position. c.972dupC has been reported in the literature in the homozygous state in individuals affected with albinism and Hermansky-Pudlak Syndrome (e.g. Wei_2022). These data indicate that the variant is likely associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 34838614). Nine submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024